The result shows that MSC derived from rats and humans can reduce TGF-β, D/P of Cr, submesothelial thickness, and α-SMA, which means whether MSCs derived from rats or humans can exert its therapeutic function in PF rat/mice models. The gene discussed is ACTA1; the disease is pemphigus foliaceus.